JPRN-UMIN000011007
Completed
Phase 3
The randomized controlled trial of the efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy. - The efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.
Department of breast and endocrine surgery, Meiwa Hospital0 sites35 target enrollmentJune 19, 2013
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- chemotherapy-induced peripheral neuropathy
- Sponsor
- Department of breast and endocrine surgery, Meiwa Hospital
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)not goshajinkigan administered 2\)with severe complications (such as liver failure, renal failure, heart failure) 3\)with history of allergy 4\)alredy adminstered with Goshajinkigan, Mecobalamin or Lafutidine. 5\)with peripheral neuropathy for other cause (such as diabetes) 6\)receiving drugs to influence peripheral neuropathy 7\)doctore's decision not to be registered to this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The randomized controlled trial of the efficacy of goshajinkigan, mecobalamin and lafutidine in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010969Department of breast and endocrine surgery, Meiwa Hospital50
Completed
Phase 3
The randomized controlled trial of the efficacy of goshajinkigan and lafutidine after mecobalamin administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010988Department of breast and endocrine surgery, Meiwa Hospital35
Completed
Not Applicable
The randomized controlled trial on the efficacy of mobile-app delivered cognitive behavioral therapy for insomniaInsomniaJPRN-UMIN000023999europsychiatric Research Institute40
Completed
Not Applicable
The randomized controlled trial on the efficacy of cognitive behavior therapy for insomniaJPRN-UMIN000014297Department of Psychophysiology, National Institute of Mental Health, National Center of Neurology & Psychiatry60
Not yet recruiting
Phase 1
A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)ITMCTR2000003033Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,